Europe’s bio-based industries are making a case for their inclusion in the continent’s rapidly evolving dual-use innovation strategy, arguing that biomanufacturing technologies could serve both civilian and defence applications.
The Bio-based Industries Consortium has published a report highlighting how biotechnology and bio-based materials might fit into Europe’s shifting approach to defence and security research. The organisation contends that dual-use engagement represents a strategic opportunity for the sector.
The EU is reconsidering its stance on defence and dual-use research amid mounting security concerns. The consortium argues that Europe cannot afford to overlook defence, space, and dual-use applications given the current geopolitical environment and the imperative for European resilience.
Central to the consortium’s argument is the potential for bio-based chemicals and materials to replace fossil-based alternatives. The organisation stresses that if dual-use engagement facilitates this transition, technology knowledge transfer must flow in both directions between defence and civilian sectors.
The report calls for upcoming EU public procurement rules to incorporate dual-use applications of bio-based materials in defence purchasing. This would create market opportunities while advancing sustainability objectives.
Biomanufacturing uses biological systems to produce materials and chemicals. Proponents suggest these technologies could reduce dependence on fossil resources while meeting defence sector requirements.
The consortium’s positioning reflects broader trends in European industrial policy. Officials are increasingly viewing strategic autonomy and technological sovereignty as essential goals. Bio-based industries are now seeking recognition as contributors to these objectives.
Whether bio-based materials will gain significant traction in defence procurement remains uncertain. The sector faces established competitors and must demonstrate that its products meet stringent military specifications.
